India’s Ranbaxy Begins U.S. Sales Of Aricept Alzheimer’s Generic
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories of India launched in the United States a generic version of Eisai's Aricept (donepezil) for treating Alzheimer's disease